Resource Library

Resource Library

Filter Resources

Area of Interest

Resource Type

      Webinar

      How incorporation of the Immunoscore result into clinical assessment for stage III colon cancer clarifies treatment decisions

      Poster

      Comprehensive biomarkers analysis to explain resistances to PD1/L1 ICIs: The Precision Immuno-Oncology for advanced Non-Small CEll Lung CancER (PIONeeR) trial.

      Poster

      Assessment of the spatial distribution of CD4+T cells subpopulations in the tumor microenvironment by Brightplex®, a sequential chromogenic multiplex assay

      Poster

      Assessment of the spatial distribution of B cells subpopulations in the tumor microenvironment and tertiary lymphoid structures by Brightplex®, a sequential chromogenic multiplex assay

      Poster

      Spatial distribution of infiltrating T lymphocytes with Immunoscore® CR T Cells Exhaustion test helps stratification of NSCLC patients treated with PD1 / PDL1 inhibitors in the PIONeeR project

      Poster

      Immunoscore® analytical performance

      Poster

      LTX-315, a first in class oncolytic peptide reshapes the tumor microenvironment inducing a local and systemic effect in metastatic tumors: Results from an ongoing study

      Poster

      Prognostic utility of immune markers and validation of Immunoscore® in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial

      Poster

      A multiplex immunohistochemistry assay for immune cells profiling on whole FFPE tumor tissue sections

      Poster

      Immunoscore IC (previously Halioseek® PD‐L1/CD8), a dual CD8 and PD‐L1 IVD assay to improve NSCLC patients stratification

    Contact our team to discuss your project